贝泰妮(300957)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300957 贝泰妮

已收盘 02-24 15:00:00

{"stockData":{"symbol":"300957","market":"SZ","secType":"STK","nameCN":"贝泰妮","latestPrice":46.9,"timestamp":1771916580000,"preClose":46.8,"halted":0,"volume":7347392,"delay":0,"changeRate":0.0021,"floatShares":424000000,"shares":424000000,"eps":0.8503,"marketStatus":"已收盘","change":0.1,"latestTime":"02-24 15:00:00","open":46.98,"high":47.48,"low":46.06,"amount":344000000,"amplitude":0.0303,"askPrice":46.91,"askSize":12,"bidPrice":46.9,"bidSize":142,"shortable":0,"etf":0,"ttmEps":0.8503,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771983000000},"marketStatusCode":5,"adr":0,"adjPreClose":46.8,"symbolType":"stock","openAndCloseTimeList":[[1771896600000,1771903800000],[1771909200000,1771916400000]],"highLimit":51.48,"lowLimit":42.12,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":423600000,"isCdr":false,"pbRate":3.26,"roa":"--","peRate":55.157003,"roe":"4.48%","epsLYR":1.2,"committee":-0.309013,"marketValue":19867000000,"turnoverRate":0.0173,"status":0,"floatMarketCap":19867000000},"requestUrl":"/m/hq/s/300957","defaultTab":"news","newsList":[{"id":"2610981563","title":"贝泰妮：截止至2026年1月30日，公司股东户数为38,366人","url":"https://stock-news.laohu8.com/highlight/detail?id=2610981563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610981563?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:54","pubTimestamp":1770796449,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月31日公司股东人数是多少？谢谢贝泰妮回复：尊敬的投资者，您好！截止至2026年1月30日，公司股东户数为38,366人。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100021639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2610640628","title":"贝泰妮2025年前三季度分配预案：拟每10股派发现金红利3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610640628","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610640628?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:35","pubTimestamp":1770723300,"startTime":"0","endTime":"0","summary":"2月10日，贝泰妮（300957）发布公告，公司拟向全体股东每10股派发现金红利3元（含税），预计总派发金额为1.26亿元。2025年前三季度，贝泰妮实现收入34.64亿元，归母净利润2.72亿元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-10/doc-inhmitaf8394228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2609596824","title":"贝泰妮：已累计成功备案18款源自云南的植物新原料","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609596824?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:12","pubTimestamp":1770383531,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮02月06日在投资者关系平台上答复投资者关心的问题。公司始终将云南特色植物资源的深度研究与产业化应用作为核心战略之一。云南被誉为“植物王国”，公司依托这一地域优势，研发团队已从数千种特色植物中系统筛选、储备并持续研究具有护肤潜力的成分。截至近期公开信息，公司已累计成功备案18款源自云南的植物新原料，数量位居行业前列。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600039385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2609596888","title":"贝泰妮：“α-丁酮酸钠”是公司在抗衰老等功效领域进行的新原料探索之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2609596888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609596888?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:12","pubTimestamp":1770383529,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮02月06日在投资者关系平台上答复投资者关心的问题。“α-丁酮酸钠”是公司在抗衰老等功效领域进行的新原料探索之一，旨在满足市场需求并拓展技术路径。相关进展将按规定及时披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600039384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2609322256","title":"2月5日贝泰妮涨5.82%，国富潜力组合混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609322256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609322256?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:41","pubTimestamp":1770280912,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日贝泰妮涨5.82%创60日新高，收盘报47.44元，换手率6.1%，成交量25.85万手，成交额12.38亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为国海富兰克林基金的国富潜力组合混合A。国富潜力组合混合A目前规模为12.54亿元，最新净值1.2，较上一交易日上涨1.61%，近一年上涨22.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500026292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2609394953","title":"股市必读：贝泰妮（300957）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394953","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394953?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:54","pubTimestamp":1770227651,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，贝泰妮报收于44.83元，上涨1.86%，换手率2.21%，成交量9.37万手，成交额4.19亿元。公司始终高度重视品牌声誉与消费者权益，对市场上各类信息保持密切关注。目前，薇诺娜等品牌在中东等新兴市场的业务正处于市场引入与本土化运营的早期阶段。交易信息汇总资金流向2月4日主力资金净流出511.75万元；游资资金净流出1109.81万元；散户资金净流入1621.56万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2608464368","title":"贝泰妮：旗下品牌已在东南亚、中东、北美、欧洲等多个国家和地区实现本土化运营与多渠道布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2608464368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608464368?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:09","pubTimestamp":1770203348,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮02月04日在投资者关系平台上答复投资者关心的问题。公司在推进国际化战略过程中，正持续完善全球渠道网络布局。目前，旗下品牌已在东南亚、中东、北美、欧洲等多个国家和地区实现本土化运营与多渠道布局。未来，我们将继续秉持审慎务实的原则，基于对不同区域市场的深入洞察，稳步推进全球业务布局。具体的国家/地区拓展计划与进展，请以公司官方披露的信息为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400035006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2608988118","title":"股市必读：贝泰妮（300957）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608988118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608988118?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:43","pubTimestamp":1769978588,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，贝泰妮报收于41.89元，下跌0.85%，换手率1.07%，成交量4.54万手，成交额1.91亿元。董秘最新回复投资者： 有消息称不少进口大牌添加了高达提取物，公司是否也有添加该提取物？公司始终坚持合法合规经营，所有产品均严格遵循国家化妆品相关法规，使用的原料安全、合规。公司不存在所述情况。当日关注点来自交易信息汇总：1月30日主力资金净流入135.86万元，呈现主动买入态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2607483960","title":"贝泰妮：公司不存在所述情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2607483960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607483960?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:30","pubTimestamp":1769776219,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：有消息称不少进口大牌添加了高达提取物，公司是否也有添加该提取物？该事件曝光对公司有何影响？贝泰妮回复：尊敬的投资者，您好！公司始终坚持合法合规经营，所有产品均严格遵循国家化妆品相关法规，使用的原料安全、合规。公司不存在所述情况。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000042733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2607705891","title":"贝泰妮：截止至2026年1月20日，公司股东户数为40,153人","url":"https://stock-news.laohu8.com/highlight/detail?id=2607705891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607705891?lang=zh_cn&edition=full","pubTime":"2026-01-29 15:09","pubTimestamp":1769670552,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)01月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月20日公司股东人数是多少？谢谢！贝泰妮回复：尊敬的投资者，您好！截止至2026年1月20日，公司股东户数为40,153人。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900019318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2606373498","title":"股市必读：贝泰妮（300957）1月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606373498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606373498?lang=zh_cn&edition=full","pubTime":"2026-01-28 02:04","pubTimestamp":1769537054,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，贝泰妮报收于42.67元，下跌0.88%，换手率1.25%，成交量5.3万手，成交额2.25亿元。董秘最新回复投资者： 公司是否持有沐曦股份、智谱华章、智元机器人、宇树科技等公司股份？公司的所有投资均严格按照法律法规及监管要求履行信息披露义务。关于具体的持股情况，请以公司在法定渠道披露的定期报告、临时公告等公开信息为准。当日关注点来自交易信息汇总：1月27日主力资金净流出992.63万元，散户资金净流入1550.4万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800001217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2606178250","title":"贝泰妮：截止至2026年1月9日，公司股东户数为40,384人","url":"https://stock-news.laohu8.com/highlight/detail?id=2606178250","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606178250?lang=zh_cn&edition=full","pubTime":"2026-01-25 23:00","pubTimestamp":1769353246,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)01月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月10日公司股东人数是多少？谢谢！贝泰妮回复：尊敬的投资者，您好！截止至2026年1月9日，公司股东户数为40,384人。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500009333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2605484491","title":"股市必读：贝泰妮（300957）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605484491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605484491?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:40","pubTimestamp":1769017221,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，贝泰妮报收于42.98元，上涨1.99%，换手率2.04%，成交量8.66万手，成交额3.69亿元。董秘最新回复投资者： 请问公司孙公司成都伊臻生物科技有限公司自主研发的注射用聚左旋乳酸填充剂正式获批上市。根据国家药品监督管理局的公开信息，成都伊臻生物科技有限公司的“注射用聚左旋乳酸填充剂”已获批三类医疗器械注册证。当日关注点来自交易信息汇总：1月21日主力资金净流入1409.25万元，呈现主力积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2605124291","title":"贝泰妮：孙公司注射用聚左旋乳酸填充剂获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2605124291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605124291?lang=zh_cn&edition=full","pubTime":"2026-01-21 11:35","pubTimestamp":1768966519,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮01月21日在投资者关系平台上答复投资者关心的问题。该产品为我国首个颞部适应症的注射填充针剂，填补了国内颞部精准抗衰治疗领域的产品空白。谢谢贝泰妮回复：尊敬的投资者，您好！根据国家药品监督管理局的公开信息，成都伊臻生物科技有限公司的“注射用聚左旋乳酸填充剂”已获批三类医疗器械注册证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100015219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2605124264","title":"贝泰妮：感谢投资者对公司产品线及市场策略提出的建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2605124264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605124264?lang=zh_cn&edition=full","pubTime":"2026-01-21 11:35","pubTimestamp":1768966519,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮01月21日在投资者关系平台上答复投资者关心的问题。建议贵公司其实可以把特护霜和浴见品牌或者泊美这些品牌组合成了一个混合套装，价格带在200-400左右，一次选择，多品牌享受，希望管理层认真考虑下贝泰妮回复：尊敬的投资者，您好！感谢您对公司产品线及市场策略提出的详细建议，我们已认真收悉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100015222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0},{"id":"2603764950","title":"股市必读：贝泰妮（300957）1月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603764950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603764950?lang=zh_cn&edition=full","pubTime":"2026-01-15 02:45","pubTimestamp":1768416310,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，贝泰妮报收于41.24元，下跌0.15%，换手率1.74%，成交量7.38万手，成交额3.07亿元。董秘最新回复投资者： 请问海南贝泰妮投资有限公司截止目前，已经投资了哪些公司？海南贝泰妮投资有限公司是公司进行产业投资与布局的重要平台之一，投资活动紧密围绕公司皮肤健康生态的战略方向展开。交易信息汇总资金流向1月14日主力资金净流出524.92万元；游资资金净流入503.96万元；散户资金净流入20.96万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500001483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2603983681","title":"贝泰妮：已实施2.35亿元股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2603983681","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603983681?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:51","pubTimestamp":1768308717,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮01月12日在投资者关系平台上答复投资者关心的问题。公司始终重视股东利益与市场关切。关于股份回购，公司已于2024年实施完成总额约2.35亿元的股份回购方案，以实际行动传递管理层对公司长期价值的信心。未来是否会实施新的回购，将严格依据法规，并综合考虑公司财务状况、战略发展及市场环境等因素审慎研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300039768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"1185238088","title":"贝泰妮股东拟减持不超过2.8%股份，减持窗口期为2月3日至5月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=1185238088","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185238088?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:09","pubTimestamp":1768223345,"startTime":"0","endTime":"0","summary":"贝泰妮（300957）发布公告称，公司股东计划通过集中竞价或大宗交易方式减持其所持有的部分公司股份，减持比例不超过公司总股本的2.8%。此次减持计划将于2024年2月3日开始，至2024年5月2日期间实施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2602517562","title":"贝泰妮：正积极推进初普品牌中国市场运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517562","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602517562?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:42","pubTimestamp":1768221728,"startTime":"0","endTime":"0","summary":"证券之星消息，贝泰妮(300957)01月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好，请问贵公司拿到的初普品牌运营权是仅限于国内，还是全球都由贝泰妮进行运营？谢谢贝泰妮回复：尊敬的投资者，您好！公司与科医人集团就初普（Tripollar）品牌达成的合作是基于双方优势互补战略合作，当前阶段，公司正集中精力积极推进该品牌在中国市场的深度运营与建设，致力于为国内消费者提供“械+妆”的专业协同价值。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200034151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300957"],"gpt_icon":0},{"id":"2602394249","title":"股市必读：贝泰妮（300957）1月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602394249","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602394249?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:13","pubTimestamp":1767895989,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，贝泰妮报收于40.45元，上涨0.52%，换手率0.98%，成交量4.16万手，成交额1.68亿元。董秘最新回复投资者： 董秘您好，注意到薇诺娜近期在哈尔滨的“特护不红街区”创新营销引发关注。薇诺娜已连续五年荣膺中国敏感肌护肤品市场销售额第一，并在2025年入选工信部首批中国消费名品。如有相关进展，公司将严格按照监管要求履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900001299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300957","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771963662599,"stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0907},{"period":"3month","weight":0.1331},{"period":"6month","weight":-0.0002},{"period":"1year","weight":0.1306},{"period":"ytd","weight":0.184}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0045},{"period":"3month","weight":0.0655},{"period":"6month","weight":0.0712},{"period":"1year","weight":0.2207},{"period":"ytd","weight":0.0374}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南贝泰妮生物科技集团股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"38366人(较上一季度减少4.45%)","perCapita":"11041股","listingDate":"2021-03-25","address":"云南省昆明市五华区高新区科医路53号","registeredCapital":"42360万元","survey":"　　云南贝泰妮生物科技集团股份有限公司的主营业务是化妆品研发、生产及销售业务。公司的主要产品是面霜、护肤水、面膜、精华以及乳液等护肤品类产品和隔离霜、粉饼、BB霜以及卸妆水等彩妆类产品。","listedPrice":47.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝泰妮(300957)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝泰妮(300957)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝泰妮,300957,贝泰妮股票,贝泰妮股票老虎,贝泰妮股票老虎国际,贝泰妮行情,贝泰妮股票行情,贝泰妮股价,贝泰妮股市,贝泰妮股票价格,贝泰妮股票交易,贝泰妮股票购买,贝泰妮股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝泰妮(300957)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝泰妮(300957)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}